Prenatal management of fetuses with supraventricular tachycardia;Résultat de la prise en charge prénatale des fœtus avec tachycardie supra-ventriculaire: À propos d'une série consécutive de 66 cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 32, Issue 4, 2003, Pages 338-344

  Jouannic, J M ^a   Delahaye, S ^a   Le Bidois, J ^b   Fermont, L ^b   Villain, E ^a   Dommergues, M ^a   Dumez, Y ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Institut de Puericulture   (France)

Author keywords

Amiodarone; Digoxin; Fetal tachycardia; Flecainide; Hydrops; Prenatal diagnosis; Sotalol

Indexed keywords

AMIODARONE; DIGOXIN; FLECAINIDE; SOTALOL; THYROID HORMONE; THYROTROPIN; ANTIARRHYTHMIC AGENT;

ARTICLE; ELECTROCARDIOGRAM; FETUS; FETUS DEATH; HEART ATRIUM FLUTTER; HORMONE SUBSTITUTION; HUMAN; HYDROPS; MAJOR CLINICAL STUDY; PRENATAL CARE; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; CLINICAL PROTOCOL; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FETUS DISEASE; FETUS HEART RATE; FETUS HYDROPS; GESTATIONAL AGE; METHODOLOGY; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; CLINICAL PROTOCOLS; DIGOXIN; ECHOCARDIOGRAPHY; FEMALE; FETAL DISEASES; FLECAINIDE; GESTATIONAL AGE; HEART RATE, FETAL; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; RETROSPECTIVE STUDIES; SOTALOL; TACHYCARDIA, ECTOPIC JUNCTIONAL; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 0141463872     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gembruch U, Redel DA, Bald R, Hansmann M. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echographic findings and pathophysiologic implications. Am Heart J 1993; 125: 1290-301.
2. Gembruch U, Krapp M, Germer U Baumann P. Venous Doppler in the sonographic surveillance of fetuses with supraventricular tachycardia. Eur J Obstet Gynecol 1999; 84: 187-92.
3. Simpson JM, Sharland GK. Fetal tachycardia: Management and outcome of 127 consecutive cases. Heart 1998; 79: 576-81.
4. Simpson LL, Marx GR, D'Alton ME. Supraventricular tachycardia in the fetus: conservative management in the absence of hemodynamic compromise. J Ultrasound Med 1997; 16: 459-64.
5. Jouannic JM, Le Bidois J, Fermont L, Villain E, Mahieu-Caputo D, Dumez Y, Dommergues M. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia. Fetal Diagn Ther 2002; 17: 120-3.
6. Van Engelen AD, Wejtens O, Brenner JI, Kleinman CS, Copel JA. Management, outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994; 24: 1371-5.
7. Jouannic JM, Delahaye S, Fermont L, Le Bidois J, Villain E, Dumez Y, Dommergues M. Fetal supraventricular tachycardia: a role for amiodarone as second line therapy? Prenat Diagn 2003; 23: 152-6.
8. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus. A report of 60 cases. Ultrasound Obstet Gynecol 1991; 1: 162-70.
9. Weiner CP, Thompson MI. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 1988; 158: 570-3.
10. Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol 1989; 160: 762-3.
11. Schmolling J, Renke K, Richter O, Pfeiffer K, Schlebusch H, Holler T. Digoxin, flecainide, and amiodarone transfert across the placenta and the effect of an elevated umbilical venous pressure on the transfer rate. Ther Drug Monit 2000; 22: 582-8.
12. Azancot-Benisty A, Jacqz-Aigrain E, Guirgis NM, Decrepy A, Oury JF, Blot P. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmia. J Pediatr 1992; 121: 608-13.
13. Pfammatter JP, Paul T. New antiarrhytmic drug in pediatric use: sotalol. Pediatr Cardiol 1997; 18: 28-34.
14. Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 1992; 15: 751-4.
15. Erkkola R, Lammintausta R, Liukko P, Anttila M. Transfer of propanolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity. Acta Obstet Gynecol Scand 1982; 61: 31-4.
16. Oudijk MA, Michon MM, Kleinman CS, Kapusta L, Stoutenbeek P, Visser GH, Meijboom EJ. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000; 101: 2721-6.
17. Owen J, Colvin EV, Davis RO. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol 1988; 158: 1169-70.
18. Kleinman CS, Copel JA. Direct fetal therapy for cardiac arrhythmias: who, what, when, why and how? Ultrasound Obstet Gynecol 1991; 1: 158-9.
19. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in treatment of fetal tachycardias. Br Heart J 1991; 65: 46-8.
20. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 1995; 15: 1209-13.
21. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19: 158-64.
22. Keef DL, Miura D, Somberg JC. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J 1986; 111: 1150-61.
23. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert Dubuc M, Gagne P, Nattel S, Thibaud B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med 2000; 342: 913-20.
24. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de estudio de la sobrevida en la insuficiencia cardiaca en Argentina (GESICA). Lancet 1994: 344: 493-8.
25. Flack NJ, Zosmer N, Bennett PR, Vaughan J, Fisk NM. Amiodarone given by three routs to terminate fetal atrial flutter associated with severe hydrops. Obstet Gynecol 1993; 82: 714-6.
26. Mangione R, Guyon F, Vergnaud A, Jimenez M, Saura R, Horovitz J. Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. Eur J Obstet Gynecol Reprod Biol 1999; 86: 105-7.
27. Arnoux P, Seyral P, Llurens M, Djiane P, Potier A, Unal D, Cano JP, Serradimigni A, Rouault F. Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol 1987; 59: 166-7.
28. Belhassen A, Vaksmann G, Francart C, Vinatier D, Patey P, Monnier JC. Value of amiodarone in the treatment of fetal supraventricular tachycardia. A propos of a case. J Gynecol Obstet Biol Reprod 1987; 16: 795-800.
29. Vlahot N, Morvan J, Bernard AM, Cleophax JP, Firmin J. Fetal supraventricular tachycardia. Prenatal treatment with a digoxin-amiodarone combination. J Gynecol Obstet Biol Reprod 1987; 16: 393-400.
30. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol 2000; 96: 575-81.
31. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in newborns. N Engl J Med 1981; 304: 702-12.
32. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid dunction and subsequent neurodevelopment. J Endocrinol Invest 2001; 24: 116-30.
33. Magree LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodaone in Canada. Am J Obstet Gynecol 1995; 172: 1307-11.
34. Magree LA, Nulman I, Rovet JF, Koren G. Neurodevelopment after in utero amiodarone exposure. Neurotoxicol Teratol 1999; 21: 261-5.
35. Schade RP, Stoutenbeek P, de Vries LS, Meijboom EJ. Neurological morbidity after fetal supraventricular tachyarrhythmia. Ultrasound Obstet Gynecol 1999; 13: 43-7.